Last 425.00
Change Today +13.32 / 3.24%
Volume 77.5K
ACT On Other Exchanges
As of 11:00 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

afrocentric investment corpo (ACT) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/20/14 - $490.00
52 Week Low
09/27/13 - $360.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

afrocentric investment corpo (ACT) Related Businessweek News

No Related Businessweek News Found

afrocentric investment corpo (ACT) Details

AfroCentric Investment Corporation Limited, an investment holding company, operates in healthcare industry. The company offers medical scheme administration and managed healthcare services. It provides health risk management services and assistance to aids-related treatments and programmes to help business care and medical scheme manage individuals living with HIV/AIDS. The company was founded in 2006 and is headquartered in Roodepoort, South Africa.

Founded in 2006

afrocentric investment corpo (ACT) Top Compensated Officers

Group Chief Executive, Director and Chief Ex...
Total Annual Compensation: R13.5M
Chief Financial Officer, Financial Director a...
Total Annual Compensation: R2.7M
Executive Officer
Total Annual Compensation: R4.2M
Executive Officer
Total Annual Compensation: R3.1M
Compensation as of Fiscal Year 2013.

afrocentric investment corpo (ACT) Key Developments

Afrocentric Investment Corp. Appoints Garth Napier as Independent Non-Executive Director

The Board of AfroCentric Investment Corporation Limited announced that Mr Garth Napier, who is currently an  Independent Non-Executive Director for the company has been appointed as the Lead Independent Non-Executive Director for the company with effect from July 2, 2014.

Afrocentric Investment Corp. Announces Unaudited Financial Results for the Six Months Ended December 31, 2013

Afrocentric Investment Corp. announced unaudited financial results for the six months ended December 31, 2013. For the period, the company reported revenue of ZAR 937.170 million against ZAR 822.422 million a year ago. Operating profit was ZAR 144.691 million against ZAR 135.183 million a year ago. Profit before income tax was ZAR 103.553 million against ZAR 99.732 million a year ago. Profit attributable to equity holders of the parent was ZAR 71.153 million against ZAR 59.529 million a year ago. Net cash inflow in operating activities was ZAR 47.127 million against ZAR 74.977 million a year ago. Diluted earnings per share was 23.51 cents against 17.81 cents a year ago. Headline earnings per diluted share was 26.09 cents against 17.63 cents a year ago.

AfroCentric Investment Corporation Limited Appoints Joint Auditors

AfroCentric Investment Corporation Limited appointed SizweNtsalubaGobodo Inc and PricewaterhouseCoopers Inc as the Company's joint external auditors for the financial year ending 30 June 2014. SizweNtsalubaGobodo Inc and PricewaterhouseCoopers Inc are the current joint external auditors for AfroCentric Health Limited and their appointment as joint auditors will mirror this service.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACT:SJ 425.00 +13.32

ACT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ACT.
View Industry Companies

Industry Analysis


Industry Average

Valuation ACT Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AFROCENTRIC INVESTMENT CORPO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at